CERTIFIES
participated in the educational CME course titled,
Novel Therapeutic Approaches to Multiple Sclerosis: BTK and Second-Generation Anti-CD40 Therapeutics
on January 22, 2026
and is awarded 1.0 AMA PRA Category 1 CreditTM.
Timothy Hayes, MD, PhD
President, AcademicCME
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME designates this enduring activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.